\
&
Contact us
Published on | 1 month ago
ProgrammesAs mentioned in this news item of last week, EIT manufacturing asbl has filed for liquidation. The European Commission has given an update regarding this procedure, through its subsidiary, the European Institute of Innovation and Technology (EIT).
The view of the European Commission and EIT headquarters is that EIT Manufacturing ASBL is an independent private legal entity, and liabilities towards beneficiaries and third parties rest with that entity. Decisions regarding its future lie with its governing bodies and members, including ensuring sufficient funding for its activities. A liquidator has been appointed on 9 April.
However, they are particularly mindful of the impact of the current situation on start-ups and other beneficiaries of EIT Manufacturing ASBL. To support beneficiaries, the EIT has published a dedicated statement on its website and established a functional mailbox (beneficiarysupport@eit.europa.eu) to respond to queries.
Please note that the European Manufacturing Conference in september 2026 has already been fully cancelled.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
AI Continent Deployment: Best use of technologies
The Digital Europe project LDT4SSC (Local Digital Twins for Smart and Sustainable Communities) has launched an Open Call for Pilots to engage European local and regional authorities, as well as a wide range of stakeholders, including public administrations at local, regional, and national levels, businesses, technology developers, suppliers, r... read more
The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities.
The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.